Estrella Immunopharma, Inc. (ESLA) Insider Trading

Estrella Immunopharma, Inc. (ESLA) has 2 SEC Form 4 insider filings on record in the last 90 days. Most recent filing: Aug. 26, 2026.

Filings
2
Purchases
0
$0
Sales
0
$0
Insiders
2

Most active ESLA insiders

Liu Cheng
CEO
0 bought · 0 sold · Aug. 26, 2026
$82K
Xu Jiandong
Chief Financial Officer
0 bought · 0 sold · Aug. 25, 2026
$82K

Latest ESLA Form 4 filings

Date Insider Value Shares Stake Pre-planned Links
Aug. 26, 2026 filed Aug. 25, 2026 Liu Cheng CEO $81,500 200,000 +13% No
Aug. 25, 2026 filed Aug. 18, 2026 Xu Jiandong Chief Financial Officer $81,500 200,000 +34% No

About this data

Form 4 is the filing company officers, directors and 10% shareholders must submit to the SEC within two business days of trading their own company's stock. Open-market purchases generally carry more signal than sales, which are often scheduled in advance. More on how this works.

Get alerted when ESLA insiders trade

Real-time Telegram alerts the moment a Form 4 is filed. Filings shown here are delayed by 72 hours.

Start free